NCT07010315

Brief Summary

To develop and test liver cancer prevention educational material.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
12mo left

Started May 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress51%
May 2025Apr 2027

Study Start

First participant enrolled

May 1, 2025

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

May 9, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 8, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2026

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2027

Expected
Last Updated

March 4, 2026

Status Verified

March 1, 2026

Enrollment Period

12 months

First QC Date

May 9, 2025

Last Update Submit

March 2, 2026

Conditions

Keywords

Liver cancerLiver diseaseFibrosisCirrhosis

Outcome Measures

Primary Outcomes (2)

  • Cognitive Testing

    Participant comprehension will be measured qualitatively through cognitive testing. In cognitive testing interviews, participants are asked to "think aloud" as they review and react to new information. Participants will be presented with the storyboard (mock-up) versions of the content and asked to describe in their own words what the information means to them. Cognitive interviews may include questions about content such as length, clarity of the language, and helpfulness of the educational material. A trained research team member will ask probing questions throughout interviews as needed. Based on patient feedback, modifications will be made iteratively to the content to ensure the content is understood and interpreted as intended. There is no post-survey for cognitive testing.

    Up to 1.5 hours

  • Usability Testing

    Usability will be measured qualitatively using a Usability Interview Guide. Usability will also be measured using the System Usability Scale. Acceptability will be measured with the Ottawa Acceptability Measures. Knowledge will be measured pre- and post- session using knowledge questions developed by the investigators and refined during cognitive testing.

    Up to 1.5 hours

Study Arms (2)

Cognitive Interviews (English and Spanish)

Participants that agree to this part of the study will be asked to view patient education materials about liver cancer, complete a demographic survey, and do an interview one-on-one either online via Zoom, over the phone, or in person at HOPE Clinic.

Behavioral: Cognitive Testing

Usability Testing (English and Spanish)

Participants will be asked to complete a pre-survey, navigate a liver cancer education website, provide their feedback and impressions, and complete a post- survey.

Behavioral: Usability Testing

Interventions

Given by surveys and one-on-one interview.

Usability Testing (English and Spanish)

Given by Survey and one-on one interviews

Cognitive Interviews (English and Spanish)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants at HOPE Clinic

You may qualify if:

  • At least 18 years old
  • Participants at the HOPE Clinic
  • Able to speak and read either English or Spanish
  • For usability testing: Able to use and navigate websites on own smart phone or study computer

You may not qualify if:

  • Has been diagnosed with liver cancer
  • Cannot provide consent or otherwise participate in research activities (e.g. vision or hearing impairment)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

MD Anderson Cancer Center

Houston, Texas, 77030, United States

RECRUITING

Related Links

MeSH Terms

Conditions

Liver NeoplasmsLiver DiseasesFibrosis

Interventions

Neuropsychological TestsUser-Centered Design

Condition Hierarchy (Ancestors)

Digestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Psychological TestsBehavioral Disciplines and ActivitiesEquipment DesignInvestigative TechniquesUniversal DesignEngineeringTechnology, Industry, and Agriculture

Study Officials

  • Jessica Hwang, MD, MPH

    M.D. Anderson Cancer Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jessica Hwang, MD, MPH

CONTACT

Study Design

Study Type
observational
Observational Model
ECOLOGIC OR COMMUNITY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 9, 2025

First Posted

June 8, 2025

Study Start

May 1, 2025

Primary Completion

April 30, 2026

Study Completion (Estimated)

April 30, 2027

Last Updated

March 4, 2026

Record last verified: 2026-03

Locations